Company news
Cspc Innovation Pharmaceutical Co., Ltd. Class A (SZSE:300765) news
Cspc Innovation Pharmaceutical Co., Ltd. Class A news releases on 6ix. Latest, Apr 28, 2026: CSPC Innovation Pharmaceutical: Q1 revenue up 40.82%…
Press releases & updates
CSPC Innovation Pharmaceutical: Q1 revenue up 40.82% year-over-year, but net loss widened on higher R&D and FX losses
April 27, 2026
CSPC Innovation Pharmaceutical: Revenue rose but higher R&D and lower margins led to a net loss; biopharma growth was strong
March 17, 2026
CSPC Innovation Submits Listing Application To Hong Kong Stock Exchange
December 10, 2025
CSPC Innovation Pharmaceutical: Revenue up 7.71% but net loss deepens; biopharma focus strengthened by Jushi stake buy
October 27, 2025
CSPC Innovation Pharmaceutical Plans To Seek Hong Kong Listing
September 30, 2025
CSPC Innovation Pharmaceutical: Revenue up, but net loss driven by R&D surge; biopharma growth and global deals highlight H1
August 15, 2025
CSPC Innovation Pharmaceutical: Revenue fell and losses widened in Q1 2025 amid R&D surge and raw material price drops
April 23, 2025
CSPC Innovation Pharmaceutical: Net profit plunged 87.63% as R&D spending rose and caffeine prices dropped, but biopharma sales soared 153%
March 20, 2025
CSPC Innovation Pharmaceutical: Revenue and profit fell significantly amid market headwinds and rising R&D costs
October 23, 2024
CSPC Innovation Pharmaceutical: Revenue and profit fell, but expansion into biologics and new drug launches signal future growth
August 16, 2024